drugset

drugset / Trial / NCT03196557

A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject

NCT03196557 ↗

Phase 1 Completed 24 enrolled Bristol-Myers Squibb

RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects

Timeline

Start: 2008-03-31
Primary completion: 2008-05-05
Completion: 2008-05-05

Publications

Hu Y, Carman JA, Holloway D, Kansal S, Fan L, Goldstine C, Lee D, Somerville JE, Latek R, Townsend R, Johnsen A, Connolly S, Bandyopadhyay S, Shadick N, Weinblatt ME, Furie R, Nadler SG. Development of a Molecular Signature to Monitor Pharmacodynamic Responses Mediated by In Vivo Administration of Glucocorticoids. Arthritis Rheumatol. 2018 Aug;70(8):1331-1342. doi: 10.1002/art.40476. Epub 2018 Jul 12.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Prednisolone	Other / unclassified	—	Oral

Indications

No indication recorded.